作者
Ronald Eccles, Guy Boivin, Benjamin J Cowling, Andrew Pavia, Rangaraj Selvarangan
发表日期
2023/7/1
来源
Clinical Infection in Practice
卷号
19
页码范围
100230
出版商
Elsevier
简介
Persons suffering from acute upper respiratory tract viral infections (URTI) commonly use over the counter (OTC) medicines to relieve symptoms such as fever, muscle aches, cough, runny nose, sore throat and nasal congestion. At present OTC medicines are only licensed for treatment of common cold and flu symptoms and not for treatment of the same symptoms associated with COVID-19. The innate immune response responsible for the mechanisms of the symptoms of URTI is the same for all respiratory viruses including SARS-CoV-2 and these symptoms can be relieved by treatment with the same OTC medicines as available for treatment of colds and flu. This review provides scientific information that OTC treatments for common cold and flu-like illness caused by respiratory viruses are safe and effective treatments for the same symptoms associated with COVID-19.
引用总数
学术搜索中的文章